Malachite green induced malignant transformation of syrian hamster embryo (SHE) cells in primary culture: Transformation is associated with enhanced expression of altered p53, bcl-2 and decreased sensitivity to apoptosis

被引:0
|
作者
Rao, KVK [1 ]
Mahudawala, DM [1 ]
Redkar, AA [1 ]
机构
[1] Tata Mem Ctr, Canc Res Inst, Cellular Carcinogenesis Lab, Bombay 400012, Maharashtra, India
关键词
malignant transformation; syrian hamster embryo cells; malachite green; p53 and bcl-2; overexpression; resistance to apoptosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malachite green (MG) consisting of green crystals with a metallic lustre, is highly soluble in water, cytotoxic to various mammalian cells and also acts as a liver tumor promoter. In view of its industrial importance and possible exposure to human beings, MG poses a potential environmental health hazard. We have previously reported the malignant transformation of Syrian hamster embryo (SHE) cells by MG. In this study, we have made an attempt to study the effects of MG on the induction of apoptosis in normal and MG transformed Syrian hamster embryo cells and the expression of altered p53 and bcl-2 immunohistochemically. Induction of apoptosis was detected by flow cytometry on the basis of G0/G1 hypodiploid peak, Tunel assay and DNA ladder pattern. Flow cytometric analysis showed a dose and time dependent induction of apoptosis by MG in control cells whereas induction of apoptosis by MG was marginal in transformed cells. Tunel assay and DNA ladder pattern also showed decreased apoptosis in transformed cells by MG compared to controls. Immunostaining studies showed intense staining for p53 in transformed cells whereas no staining was observed in control cells. Also transformed cells showed overexpression of bcl-2 with exclusive nucelar localization compared to controls which did not show staining. The present study indicated that MG transformed Syrian hamster embryo cells have decreased sensitivity to apoptosis compared to normal cells and overexpression of altered p53 and bcl-2 seems to be conferring resistance to MG induced apoptosis.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 26 条
  • [21] Nutlin-3 Promotes TRAIL-Induced Liver Cancer Cells Apoptosis by Activating p53 to Inhibit bcl-2 and Surviving Expression
    Zhang, Caogeng
    Ni, Juping
    Fan, Wei
    Hou, Ju
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2022, 52 (04): : 601 - 610
  • [22] Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells
    Jiang, MC
    YangYen, HF
    Lin, JK
    Yen, JJY
    ONCOGENE, 1996, 13 (03) : 609 - 616
  • [23] Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells
    Zhang, XW
    Xu, B
    ANTI-CANCER DRUGS, 2000, 11 (09) : 747 - 756
  • [24] Taxol mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells:: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest
    Roth, W
    Wagenknecht, B
    Grimmel, C
    Dichgans, J
    Weller, M
    BRITISH JOURNAL OF CANCER, 1998, 77 (03) : 404 - 411
  • [25] Isololiolide, a carotenoid metabolite isolated from the brown alga Cystoseira tamariscifolia, is cytotoxic and able to induce apoptosis in hepatocarcinoma cells through caspase-3 activation, decreased Bcl-2 levels, increased p53 expression and PARP cleavage
    Vizetto-Duarte, Catarina
    Custodio, Luisa
    Gangadhar, KatkamN.
    Lago, Joao Henrique G.
    Dias, Catarina
    Matos, Ana Marta
    Neng, Nuno
    Florencio Nogueira, Jose Manuel
    Barreira, Luisa
    Albericio, Fernando
    Rauter, Amelia P.
    Varela, Joao
    PHYTOMEDICINE, 2016, 23 (05) : 550 - 557
  • [26] Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest
    W Roth
    B Wagenknecht
    C Grimmel
    J Dichgans
    M Weller
    British Journal of Cancer, 1998, 77 : 404 - 411